Opinion

Video

Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Medical Illustration Atherosclerosis, Cholesterol Plaque, Blood Clot in Artery, Cardiovascular Disease.
May 22nd 2025

Risk of Cardiovascular Event Increases With Rising Lipoprotein(a) Levels in Patients With ASCVD

Luke Halpern, Assistant Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Atherosclerosis Animation: Cholesterol Plaque Formation, Rupture, and Blood Clot in Artery
May 9th 2025

Plozasiran Shows Promise as Cholesterol-Lowering Treatment for Mixed Hyperlipidemia

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Researchers Call for Better Risk Stratification Methods in Older Individuals With Hypercholesterolemia
May 1st 2025

Researchers Call for Better Risk Stratification Methods in Older Individuals With Hypercholesterolemia

Aislinn Antrim, Managing Editor
Effects and treatment of statins concept photo. Open packaging with drugs tablets, on which is written "Statin Medication", lies near stethoscope, result analysis on cholesterol (lipid panel) and ECG
April 25th 2025

Many Patients With Elevated LDL Cholesterol Are Not Prescribed Lipid-Lowering Medication

Luke Halpern, Assistant Editor
OSZAR »